A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease

[1]  Pierrick Bourgeat,et al.  Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease , 2016, Alzheimer's & Dementia.

[2]  Daniel R. Schonhaut,et al.  PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.

[3]  Yi Su,et al.  Local and distributed PiB accumulation associated with development of preclinical Alzheimer's disease , 2016, Neurobiology of Aging.

[4]  Jorge Sepulcre,et al.  Tau positron emission tomographic imaging in aging and early Alzheimer disease , 2016, Annals of neurology.

[5]  W. M. van der Flier,et al.  Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. , 2015, Journal of Alzheimer's disease : JAD.

[6]  William Jagust,et al.  Is amyloid-β harmful to the brain? Insights from human imaging studies. , 2016, Brain : a journal of neurology.

[7]  Reisa A. Sperling,et al.  CAP—advancing the evaluation of preclinical Alzheimer disease treatments , 2016, Nature Reviews Neurology.

[8]  C. Rowe,et al.  Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment. , 2015, Age and ageing.

[9]  Richard N. Jones,et al.  Development of a subjective cognitive decline questionnaire using item response theory: A pilot study , 2015, Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring.

[10]  B. Snitz,et al.  Do Subjective Memory Complaints Lead or Follow Objective Cognitive Change? A Five-Year Population Study of Temporal Influence , 2015, Journal of the International Neuropsychological Society.

[11]  W. M. van der Flier,et al.  Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. , 2015, Journal of Alzheimer's disease : JAD.

[12]  F. Jessen,et al.  Mortality in Individuals with Subjective Cognitive Decline: Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). , 2015, Journal of Alzheimer's disease : JAD.

[13]  Keith A. Johnson,et al.  Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly , 2015, Neurology.

[14]  A. Tales,et al.  To revitalize neurology we need to address physician burnout , 2015, Neurology.

[15]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[16]  R. Sperling,et al.  Establishing Clinical Relevance in Preclinical Alzheimer's Disease. , 2015, The journal of prevention of Alzheimer's disease.

[17]  F. Jessen,et al.  Cognitive performance before and after the onset of subjective cognitive decline in old age , 2015, Alzheimer's & dementia.

[18]  R. Sperling,et al.  Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument. , 2015, JAMA neurology.

[19]  F. Jessen,et al.  Incident subjective memory complaints and the risk of subsequent dementia , 2015, Acta psychiatrica Scandinavica.

[20]  F. Jessen,et al.  Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI , 2015, Neurology.

[21]  Paul Maruff,et al.  Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing , 2015, Neurobiology of Aging.

[22]  C. Rowe,et al.  Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. , 2015, Neuropsychology.

[23]  P. Snyder,et al.  Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. , 2014, Journal of Alzheimer's disease : JAD.

[24]  N. Kowall,et al.  Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders. , 2014, Journal of Alzheimer's disease : JAD.

[25]  M. Saling,et al.  Subjective Cognitive Decline from a Phenomenological Perspective: A Review of the Qualitative Literature. , 2015, Journal of Alzheimer's disease : JAD.

[26]  G. Grossberg,et al.  Amyloid and Tau Biomarkers in Subjective Cognitive Impairment. , 2015, Journal of Alzheimer's disease : JAD.

[27]  A. Mitchell,et al.  Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta‐analysis , 2014, Acta psychiatrica Scandinavica.

[28]  C. Jack.  PART and SNAP , 2014, Acta Neuropathologica.

[29]  Andrew J. Saykin,et al.  A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease , 2014, Alzheimer's & Dementia.

[30]  F. Schmitt,et al.  Self-reported memory complaints , 2014, Neurology.

[31]  F. Jessen.  Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer’s disease , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[32]  R. Sperling,et al.  Alzheimer's disease research and development: a call for a new research roadmap , 2014, Annals of the New York Academy of Sciences.

[33]  J. Karlawish,et al.  The A4 Study: Stopping AD Before Symptoms Begin? , 2014, Science Translational Medicine.

[34]  P. Selnes,et al.  Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers , 2013, Dementia and Geriatric Cognitive Disorders Extra.

[35]  Wiesje M. van der Flier,et al.  Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints , 2013, Alzheimer's & Dementia.

[36]  C. Rowe,et al.  Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age , 2013, International Psychogeriatrics.

[37]  R. Katz,et al.  Regulatory innovation and drug development for early-stage Alzheimer's disease. , 2013, The New England journal of medicine.

[38]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[39]  Henrik Zetterberg,et al.  Cerebrospinal fluid biomarkers mirror rate of cognitive decline. , 2013, Journal of Alzheimer's disease : JAD.

[40]  K. Blennow,et al.  Diagnostic power of 24S-hydroxycholesterol in cerebrospinal fluid: candidate marker of brain health. , 2013, Journal of Alzheimer's disease : JAD.

[41]  Matthew L Senjem,et al.  Indicators of amyloid burden in a population-based study of cognitively normal elderly , 2012, Neurology.

[42]  Reisa A. Sperling,et al.  Subjective cognitive complaints and amyloid burden in cognitively normal older individuals , 2012, Neuropsychologia.

[43]  Michael Wagner,et al.  Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment , 2012, Neurology.

[44]  F. Jessen,et al.  Glucose metabolism, gray matter structure and memory decline in subjective memory impairment , 2012, Alzheimer's & Dementia.

[45]  H. Buschke,et al.  Predicting Alzheimer's Disease: Neuropsychological Tests, Self‐Reports, and Informant Reports of Cognitive Difficulties , 2012, Journal of the American Geriatrics Society.

[46]  Elizabeth C Mormino,et al.  Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. , 2012, Archives of neurology.

[47]  Dietmar R. Thal,et al.  Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years , 2011, Journal of neuropathology and experimental neurology.

[48]  Carole Dufouil,et al.  Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study. , 2011, The British journal of psychiatry : the journal of mental science.

[49]  K. Blennow,et al.  Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment. , 2011, Journal of Alzheimer's disease : JAD.

[50]  Susan M. Resnick,et al.  Subjective cognitive complaints and longitudinal changes in memory and brain function. , 2011, Neuropsychology.

[51]  Olivier Salvado,et al.  Larger temporal volume in elderly with high versus low beta-amyloid deposition. , 2010, Brain : a journal of neurology.

[52]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[53]  F. Jessen,et al.  Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. , 2010, Archives of general psychiatry.

[54]  C. J. Whitaker,et al.  Appraisal of Memory Functioning and Memory Performance in Healthy Ageing and Early-Stage Alzheimer's Disease , 2010, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

[55]  Wei Zhu,et al.  Outcome over seven years of healthy adults with and without subjective cognitive impairment , 2010, Alzheimer's & Dementia.

[56]  R. Sperling.  CRITERIA FOR PRECLINICAL ALZHEIMER ’ S DISEASE – June 2 , 2010 Preclinical Alzheimer ’ s Disease Workgroup , 2010 .

[57]  Magda Tsolaki,et al.  Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study , 2009, The Lancet Neurology.

[58]  Jeffrey A. James,et al.  Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.

[59]  A. Mitchell,et al.  The clinical significance of subjective memory complaints in the diagnosis of mild cognitive impairment and dementia: a meta‐analysis , 2008, International journal of geriatric psychiatry.

[60]  Mony J. de Leon,et al.  Hypometabolism and Altered Cerebrospinal Fluid Markers in Normal Apolipoprotein E E4 Carriers with Subjective Memory Complaints , 2008, Biological Psychiatry.

[61]  B. Reisberg,et al.  Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease , 2008, International Psychogeriatrics.

[62]  K. Blennow,et al.  Cerebrospinal Fluid Biomarkers Predict Decline in Subjective Cognitive Function over 3 Years in Healthy Elderly , 2007, Dementia and Geriatric Cognitive Disorders.

[63]  A. Hofman,et al.  Subjective memory complaints, education, and risk of Alzheimer’s disease , 2007, Alzheimer's & Dementia.

[64]  Lukas Scheef,et al.  Volume reduction of the entorhinal cortex in subjective memory impairment , 2006, Neurobiology of Aging.

[65]  D. A. Bennett,et al.  Memory complaints are related to Alzheimer disease pathology in older persons , 2006, Neurology.

[66]  A. Saykin,et al.  Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI , 2006, Neurology.

[67]  Li Wang,et al.  Subjective Memory Deterioration and Future Dementia in People Aged 65 and Older , 2004, Journal of the American Geriatrics Society.

[68]  Faiza Admiraal-Behloul,et al.  Memory complaints in patients with normal cognition are associated with smaller hippocampal volumes , 2004, Journal of Neurology.

[69]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[70]  Keith A. Johnson,et al.  Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.

[71]  L M Bouter,et al.  Memory complaints and APOE-ε4 accelerate cognitive decline in cognitively normal elderly , 2001, Neurology.

[72]  C. Jonker,et al.  Are memory complaints predictive for dementia? A review of clinical and population‐based studies , 2000, International journal of geriatric psychiatry.